Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid LeukemiaPinkal Desai, Farhad Ravandi, Saar Gill et al.|Journal of Clinical Oncology|2021Cited by 21